AFP and hepatocellular carcinoma: The association of AFP response with radiological response and prognosis has been assessed in large cohorts of patients with HCC, including those treated with surgical resection, radiofrequency ablation, transarterial chemoembolization, cytotoxic chemotherapy and molecular targeted therapy, and can potentially guide clinical practice in the majority of cases (16–20).